GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allmed Solutions Ltd (XTAE:ALMD) » Definitions » YoY EBITDA Growth

Allmed Solutions (XTAE:ALMD) YoY EBITDA Growth : -1.14% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Allmed Solutions YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Allmed Solutions's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -1.14%.

Allmed Solutions's EBITDA per Share for the six months ended in Dec. 2023 was ₪-0.09.


Allmed Solutions YoY EBITDA Growth Historical Data

The historical data trend for Allmed Solutions's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allmed Solutions YoY EBITDA Growth Chart

Allmed Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 420.08 -110.95 153.93 -372.92 113.74

Allmed Solutions Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.75 -132.43 -35.38 413.89 -1.14

Allmed Solutions YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Allmed Solutions's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.018--0.131)/ | -0.131 |
=113.74 %

Allmed Solutions's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.089--0.088)/ | -0.088 |
=-1.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allmed Solutions YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Allmed Solutions's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Allmed Solutions (XTAE:ALMD) Business Description

Traded in Other Exchanges
N/A
Address
2 Ha-Eshel Street, P.O.BOX 3081, Caesarea Industrial Park, Caesarea, ISR, 3079501
Allmed Solutions Ltd is a medical device company. It researches, develops, manufactures and markets peripheral stents and medical devices. It has developed a proprietary stent technology platform to expedite the development of site-specific stents. It also develops medical devices focused on minimal invasive therapy for the treatment of type 2 diabetes.

Allmed Solutions (XTAE:ALMD) Headlines

No Headlines